Candesartan cilexetil is an ester prodrug antagonist to angiotensin II receptor type 1 (AT1) used in management of many cardiovascular diseases. The absolute bioavailability of …
AS Ertürk, MU Gürbüz, M Tülü - Pharmaceutical development and …, 2017 - Taylor & Francis
This article investigates the aqueous solubility of the poorly soluble drug candesartan cilexetil (CC) in the presence of poly (amidoamine)(PAMAM) dendrimers. The effect of …
Candesartan cilexetil (CC) is an antihypertensive drug. It has low solubility and faces hepatic first-pass metabolism after oral ingestion. We formulated bioadhesive buccal films …
AA Bayoumi - Asian J Pharm Clin Res, 2018 - researchgate.net
Objective: The goal of this study was to formulate ticagrelor tablets with enhanced dissolution rate using cogrinding technique. However, it belongs to the biopharmaceutical …
MH AL-GBURI - Int J App Pharm, 2022 - pdfs.semanticscholar.org
Objective: This study was employed to evaluate the quality of marketed oral tablets containing clopidogrel bisulfate. Tablets produced by various companies and …
Objective: The objective of this study is to evaluate callinectes chitosan as a superdisintegrant in tablet formulation; superdisintegrants are incorporated into tablets at …
Objective: The current research objective is systematic development and characterization of binary and ternary inclusion complexes of cefuroxime axetil with β-cyclodextrin to improve its …
Objective: The present study was performed to compare the quality of conventional tablets loaded with candesartan cilexetil. The selected candesartan cilexetil tablets were …
OS Salih, RA Nief - Asian J Pharm Clin Res, 2016 - academia.edu
Objective: The objective of this study is to develop a controlled release matrix tablet of candesartan cilexetil to reduce the frequency of administration, enhance bioavailability and …